Lateral Care has filed a notice of an exempt offering of securities to raise $11,305,000.00 in New Funding.

According to filings with the U.S. Securities and Exchange Commission, Lateral Care is raising up to $11,305,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About Lateral Care
LateralCare is a healthcare technology company focused on revenue cycle management (RCM). Its flagship product, revenue alai, is an AI-native platform designed to support a new era of healthcare revenue cycle operations. The company positions AI as a way to expand what is possible in revenue cycle management. LateralCare emphasizes trusted partnerships and real-world impact as central to its approach. The website presents revenue alai as the companys primary offering and identifies LateralCare as its developer.

To learn more, visit https://www.lateralcare.com/
LinkedIn: https://www.linkedin.com/company/lateralcare/

Contact:
Sowri Krishnan, Founder/Chairman
https://www.linkedin.com/in/sowris/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.